Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1960 Oct;152(4):594–600. doi: 10.1097/00000658-196010000-00004

Effects of Alkylating Drugs and a Combinations of X-irradiation and Cortisone on Tumor Immunity *

Frederick W Preston, Elizabeth Jane Jackson, George C Henegar, Robert Schrek
PMCID: PMC1613789  PMID: 13737890

Full text

PDF
594

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON M. C., STALEY C. J., SCANLON E. F., PRESTON F. W. Use of triethylene thiophosphoramide (thio-TEPA) in treatment of advanced cancer. AMA Arch Surg. 1957 Oct;75(4):615–624. doi: 10.1001/archsurg.1957.01280160125016. [DOI] [PubMed] [Google Scholar]
  2. BAKER R., GORDON R., HUFFER J., MILLER G. H., Jr Experimental renal transplantation: I. Effect of nitrogen mustard, cortisone, and splenectomy. AMA Arch Surg. 1952 Nov;65(5):702–705. doi: 10.1001/archsurg.1952.01260020694008. [DOI] [PubMed] [Google Scholar]
  3. FARHAT S. M., AMER N. S., WEEKS D. S., MUSSELMAN M. M. Effect of mechlorethamine hydrochloride (nitrogen mustard) on healing of abdominal wounds. AMA Arch Surg. 1958 May;76(5):749–753. doi: 10.1001/archsurg.1958.01280230089013. [DOI] [PubMed] [Google Scholar]
  4. FARHAT S. M., MILLER D. M., MUSSELMAN M. M. Effect of triethylenethiophosphoramide (thio-TEPA) upon healing of abdominal wounds. AMA Arch Surg. 1959 May;78(5):729–731. doi: 10.1001/archsurg.1959.04320050061009. [DOI] [PubMed] [Google Scholar]
  5. LEVINSON M. E., NECHELES H. Successful prolongation of survival of skin homografts. Plast Reconstr Surg (1946) 1956 Mar;17(3):218–219. doi: 10.1097/00006534-195603000-00005. [DOI] [PubMed] [Google Scholar]
  6. MORALES F., McDONALD G. O. Toxicity of nitrogen mustard in relation to operations. Surg Forum. 1957;8:173–177. [PubMed] [Google Scholar]
  7. MRAZEK R., ECONOMOU S., MCDONALD G. O., SLAUGHTER D. P., COLE W. H. Prophylactic and adjuvant use of nitrogen mustard in the surgical treatment of cancer. Ann Surg. 1959 Oct;150:745–755. doi: 10.1097/00000658-195910000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PHILIPS F. S. Recent contributions to the pharmacology of bis(2-haloethyl) amines and sulfides. J Pharmacol Exp Ther. 1950 Aug;99(42):281–323. [PubMed] [Google Scholar]
  9. PRESTON F. W., JACKSON E. J., HENEGAR G. C., SCHREK R. Antitumor effects of homologous immune serum, immune lymphocytes and nitrogen mustard against a rat lymphoma. Surg Forum. 1958;9:583–587. [PubMed] [Google Scholar]
  10. PRESTON F. W., JACKSON E. J., HENEGAR G. C. Tumor inhibiting effect of homologous living cells against a rat lymphosarcoma. Surg Forum. 1960;10:14–17. [PubMed] [Google Scholar]
  11. SCHREK R., PRESTON F. W. An antitumor factor in the blood of tumor immune rats. Surg Forum. 1955;5:631–637. [PubMed] [Google Scholar]
  12. SCHREK R., PRESTON F. W. Cytotoxicity of a homologous immune serum to a transplantable rat tumor by the method of unstained cell counts. Cancer Res. 1957 Feb;17(2):102–107. [PubMed] [Google Scholar]
  13. SCHREK R., PRESTON F. W. Toxicity of homologous immune serum to a transplantable tumor: studies using phase microscopy and cinemicrography. J Natl Cancer Inst. 1956 Feb;16(4):1021–1045. [PubMed] [Google Scholar]
  14. SHIMKIN M. B., MOORE G. E. Adjuvant use of chemotherapy in the surgical treatment of cancer; plan of cooperative study. J Am Med Assoc. 1958 Aug 2;167(14):1710–1714. doi: 10.1001/jama.1958.02990310016003. [DOI] [PubMed] [Google Scholar]
  15. TOOLAN H. W. Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H.S. No. 1; H.Ep. No. 1; H.Ep. No. 2; H.Ep. No. 3; and H.Emb.Rh. No. 1. Cancer Res. 1954 Oct;14(9):660–666. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES